Sakitamiwa Classification 🎁 Must See

Delivery address
135-0061

Washington

Change
Sweet point
buy later
Category
Cart0items

Change delivery address

The "delivery date" and "inventory" displayed in search results and product detail pages vary depending on the delivery destination.
Current delivery address is
Washington (135-0061)
 is set to .
If you would like to check the "delivery date" and "inventory" of your desired delivery address, please make the following changes.

■Select from address book (for members)
Login

■Enter the postal code and set the delivery address (for those who have not registered as members)

post code - Search for address by entered postal code

*Please note that setting the delivery address by postal code will not be reflected in the delivery address at the time of ordering.
*Inventory indicates the inventory at the nearest warehouse.
*Even if the item is on backorder, it may be delivered from another warehouse.

  • Do not change
  • Check this content

    Sakitamiwa Classification 🎁 Must See

    | Resource Level | Minimum required for Stages I–II | For Stages III–IV | |----------------|----------------------------------|------------------| | (clinic) | Tourniquet test, platelet count, urine dipstick | Transfer to district hospital | | Medium (hospital) | Rapid NS1 antigen test, bedside ultrasound for ascites | Complete blood count, ALT, creatinine, chest X-ray | | High (tertiary) | Quantitative RT-PCR for V-score, serum angiopoietin-2 | CT brain, continuous renal replacement therapy |

    | Stage | n (%) | 14-day mortality | Progression to higher stage | Likelihood of severe bleeding | |-------|-------|------------------|-----------------------------|-------------------------------| | 0 | 310 (25.8%) | 0.0% | 2.3% | 0% | | I | 487 (40.4%) | 1.2% | 8.7% | 0.4% | | II | 255 (21.2%) | 8.6% | 21.2% | 5.1% | | III | 112 (9.3%) | 41.1% | 33.0% | 38.4% | | IV | 40 (3.3%) | 72.5% | N/A | 67.5% | sakitamiwa classification

    A validated point-of-care score – the – combines age > 55 years, platelet count < 70,000/μL, and a positive non-structural protein 1 (NS1) antigen result. SSI ≥ 4 predicts Stage III with 89% sensitivity. 4. Prognostic Value and Treatment Algorithms A prospective cohort of 1,204 patients (2021–2023) demonstrated the classification’s predictive power: | Resource Level | Minimum required for Stages